Aging is associated with complex structural and functional alterations in the vasculature (1) (2) (3) (4) (5) . Many reports have shown that at a blood cholesterol level of 240 mg/dl, the risk of coronary heart disease begins to rise sharply (6) (7) (8) (9) (10) (11) . However, people with levels of LDL-cholesterol below 130 mg/dl have a longer and better quality of life then the people with high levels of cholesterol (12) (13) (14) (15) (16) (17) . Cholesterol in hepatocytes synthesize bile salts, which are crucial for the proper solubilization of dietary fats (18) (19) (20) (21) (22) (23) . This reaction represents the major route for removal of cholesterol from the body. Increasing the turnover of bile salts has a beneficial effect on low-density lipoprotein cholesterol levels, which is an important risk factor for the development of atherosclerosis and playa relevant role in aging (24) (25) (26) (27) (28) (29) . Elevated plasma LDL cholesterol and triglyceride levels and reduced HDL cholesterol levels are associated with an increased risk of developing atheroma and shorter life (30-35).
Dysfunction of both the vascular endothelium and smooth muscle cells appears to occur as age progresses which represent one of the main risk factors for the development of vascular diseases. Vascular endothelium has strategic location between the plasma and the underlying tissue and is an active paracrine, endocrine, and autocrine organ that is indispensable for the regulation of vascular tone and the maintenance of vascular homeostasis (36) (37) (38) (39) (40) (41) . Macrophages, fibroblasts, and endothelial cells all move into wounds at the same time. Macrophages augment inflammatoryresponses and secretevascular endothelial growth factor (VEGF), a key cytokine that mediates angiogenesis and inflammatory response (42) (43) (44) (45) (46) (47) . VEGF-A, also called VEGF, is the major vascular growth factor in blood vessel maturation, although many other angiogenic factors, for example, fibroblast growth factor, transforming growth factor p and angiopoietins, can enhance capillary growth (48) . The expression ofVEGF-A is regulated mainly at the transcriptional level, although its expression and activity can be controlled by posttranscriptional, translational and posttranslational mechanisms (48) . VEGF family members regulate endothelial cell proliferation and migration. The effects of VEGF, promote angiogenesis and are mediated by the internalization ofits receptor.The inhibition ofVEGF and its receptor decreases the tumor vascularization and indicates a reduction of tumor (48) (49) (50) (51) (52) (53) .
Uptake of modified LDL, such as oxidized LDL cholesterol, via scavenger receptors on macrophages, is critical to the formation of foam cells (54) (55) (56) (57) (58) (59) . Subsequent accumulation leads to the formation of fatty steaks and ultimately advanced atherosclerotic lesions ( Fig. 1 ).
Vascular endothelial dysfunction occurs during the human aging process and is an independent risk factor for the development of atherosclerosis and hypertension (60) (61) (62) (63) (64) (65) . Injury to the vessel wall leads to intimal smooth muscle cell proliferation and luminal occlusion. In addition, accumulation oflipids in the vascular endothelium activates complement and triggers intravascular thrombosis and necrosis of the vessel wall (66) (67) (68) (69) (70) .
Alterations of endothelial physiology, m atherogenesis represent an important early step in the development of atherosclerosis and are also involved in plaque progression and the occurrence of many complications in atherosclerosis (71) (72) (73) (74) (75) (76) .
The dysfunction of endothelial is mostly due to the reduction of vasodilator NO and other events. Leukocyte activation, including effector cells, produces chemokines which participate in the recruitment of other leukocytes such as macrophages (77) (78) (79) (80) . Activated macrophages stimulate acute inflammation through the secretion of cytokines and chemokines, and short-lived lipid mediators such as prostaglandin, leukotrienes and platelet activating factor (PAF) (81) (82) (83) . The collective action of these compounds is to produce a local inflammation. Moreover, activated macrophages induce the formation of repair tissue by secreting growth factors that stimulate new blood vessel formation or angiogenesis. Endothelial cell activation is characterized. by the synthesis and secretion of cytokines such as interleukins, TNFa, angiotensin II, vascular endothelial growth factor and the expression of CAMs: intercellular adhesion molecule-1 (lCAM-1), vascular cell adhesion molecule-I (VCAM-1), E and P selectin and chemokines, such as the monocyte chemoattractant protein-1 (MCP-1) and fractalkine. The secretion of growth factors, cytokines and chemokines, trigger 'l-Iymphocytes and monocyte recruitment, diapedesis and homing within the subendothelium (84) (85) (86) .
The link between hypercholesterolemia, atherosclerosis and aging is poorly understood. Low-density lipoprotein (LDL) (cholesterol) in general is an important physiological compound for cellular function, but in high concentrations, it can lead to atheroma formation (87) (88) (89) . It is generally accepted that the oxidized form of cholesterol leads to endothelial dysfunction, an initial step in the formation of an atheroma. Oxidized lowdensity lipoprotein acts via binding to a number of scavenger receptors (SR), such as SR-AI, SR-A2, and can up-regulate expression of its own receptor LOX-Ion endothelial cells and activate these cells (90) (91) (92) . Moreover, oxidized low-density lipoprotein promotes the growth and migration ofsmooth muscle cells, fibroblasts and macrophages. In physiological conditions, endothelial cells secrete a large variety of factors, monitor the transport of plasma molecules, and regulate vascular tone. Moreover, endothelial cells are involved in the regulation of cholesterol and lipid homeostasis, signal transduction, immunity, and inflammation (93) . In human vascular lesions is mostly due to hyper-cholesterolaemia which can be induced by dietary supplementation, hepatic overproduction of lipoproteins or by genetic mutations of lipid receptors.
Hyperlipidaemia is one of the main risk factors for vascular injury, including hypertension, diabetes, and aging (94) (95) (96) . Endothelial cells are involved in atherogenesis and their dysfunction is a key early event in plaque formation. The generation of atheroma includes a sequence of events leading to fatty streak and fibro-fatty plaque formation in humans (97) (98) (99) . People with low level of cholesterol have less atheroma formations and longer life.
Atherosclerotic tissue produce high levels of ROS, and oxLDL accumulate in the atheroma which overexpress VCAM-I and eNOS. Lowering LDL reduces ROS production, oxLDL accumulation, VCAM-I, MCP-I, and plasma levels of anti-oxLDL IgG (100-101). These data are in accordance with several authors who report that cholesterol lowering reduces oxidative stress and endothelial cell activation (102) (103) (104) (105) (106) .
It has been demonstrated repeatedly that fat increases monocyte-endothelial interactions and the endothelial expression of the pro-atherogenic vascular cell adhesion molecule-l (VCAM-I). The aim ofthis study is to examine molecular mechanisms involved in the effect of cholesterol on VCAM-I expression. Treatment with cholesterol also led to the activation of NF-KB and induction of IKBalpha phosphorylation, thus accounting for NF-KB translocation into the nucleus. Pathophysiological cholesterol concentrations increase VCAM-I expression and activate NF-KB. This mostly occurs through stimulation of p38MAP (107-III).
It has been also reported by several authors that HDL may inhibit atherosclerosis by promoting healthy endothelial function and by limiting or inhibiting the activation of macrophages and other immune cells (112) (113) (114) (115) (116) . HDL, generally considered to be cardio-protective, may regulate immune system function and participate in the process of reverse cholesterol transport by inhibiting growth factor and cytokine receptors. These observation suggest that HDL has a therapeutic potentiality in treating acute and chronic inflammation in the dynamic of atheroma generation. 
